文献速递冠心病

FUSION试验:CT衍生血流储备分数用于稳定性冠心病诊断路径

Addition of Computed Tomography-Derived Fractional Flow Reserve in the Diagnostic Pathway of Patients With Stable Coronary Artery Disease: The FUSION Randomized Controlled Trial.
PubMed 文献 · J Am Coll Cardiol · 2026-08-28

FUSION为多中心随机对照试验,纳入CCTA显示50%–90%狭窄的稳定性冠心病患者528例,随机分为FFRct引导组与常规诊疗组。90天时FFRct组无阻塞性冠脉的ICA发生率显著低于常规组(18% vs 33%,OR 0.46,95%CI 0.31–0.69,P<0.001),ICA使用率亦降低。两组血运重建率、生活质量、费用及主要不良心脏事件无差异。

要点

  • CCTA 50%–90%狭窄患者加用FFRct可减少无阻塞性冠脉的ICA。
  • FFRct组90天ICA使用率降低(39% vs 51%,P=0.004)。
  • 两组1年血运重建率、生活质量、费用及事件率无差异。

核心结论

  • 在CCTA 50%–90%狭窄患者诊断路径中加入FFRct,可降低90天和1年无阻塞性冠脉的ICA发生率,且不增加血运重建、生活质量或费用差异。

研究设计与样本

  • FUSION为研究者发起、多中心、随机对照试验,纳入CCTA显示至少1支冠脉50%–90%狭窄的患者528例,随机分为FFRct引导组(n=263)与常规诊疗组(n=265)。

主要发现

  • 90天无阻塞性冠脉的ICA发生率FFRct组为18%(48/263),常规组为33%(87/265),OR 0.46,95%CI 0.31–0.69,P<0.001。
  • 90天ICA使用率FFRct组为39%(102/263),常规组为51%(136/265),P=0.004。
  • 1年血运重建率两组均为20%(52/263 vs 53/265),P=0.948。
  • 两组生活质量、费用及主要不良心脏事件无差异,但临床事件率较低。

临床怎么用

  • 对CCTA显示50%–90%狭窄的稳定性冠心病患者,可考虑在诊断路径中加入FFRct以减少不必要的ICA。

局限性

  • 临床事件率较低,可能限制对主要不良心脏事件差异的评估。
  • ICA使用率为事后探索性终点。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Computed tomography-derived fractional flow reserve (FFRct) integrates anatomical and functional information, which is particularly useful for stable coronary artery disease (CAD) patients with at least intermediate stenosis. OBJECTIVES: We investigated the impact of adding FFRct to the diagnostic pathway of CAD patients with a 50% to 90% stenosis on coronary computed tomography angiography (CCTA). METHODS: FUSION is an investigator-initiated, multicenter, randomized controlled trial involving patients with 50% to 90% stenosis in ≥1 coronary artery on CCTA. Patients were randomized to FFRct-guided or usual care. The primary endpoint was invasive coronary angiography (ICA) without obstructive CAD at 90 days. Secondary endpoints included ICA without obstructive CAD, major adverse cardiac events, and costs at 1 year, as well as revascularizations, and quality of life at 90 days and 1 year. ICA use was assessed as a post hoc exploratory endpoint. RESULTS: Overall, 528 patients (median age: 63 years [25th-75th: 57-69 years]; 59% male) were randomized to FFRct-guided (n = 263) or usual care (n = 265). At 90 days, the rate of ICA without obstructive CAD was significantly lower in the FFRct group than in the usual care group (18% [48 of 263] vs 33% [87 of 265]; OR: 0.46; 95% CI: 0.31-0.69; P < 0.001). ICA rate was 39% (102 of 263) vs 51% (136 of 265), respectively (P = 0.004). Both differences persisted at 1 year. Revascularization rates were similar: 20% (52 of 263) vs 20% (53 of 265) at 1 year, respectively (P = 0.948). Quality of life, costs, and major adverse cardiac events did not differ between groups, although the clinical event rates were low. CONCLUSIONS: Adding FFRct to the diagnostic pathway of patients with a 50% to 90% stenosis on CCTA reduced the rate of ICA without obstructive CAD at 90 days and 1 year, without differences in revascularizations, quality of life, and costs compared with usual care. Clinical event rates were similar, although low. The rate of overall ICA use, a post hoc exploratory outcome, was also reduced at 90 days and 1 year.

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Sharma SP, Budde RPJ, van der Zee PM, et al. Addition of Computed Tomography-Derived Fractional Flow Reserve in the Diagnostic Pathway of Patients With Stable Coronary Artery Disease: The FUSION Randomized Controlled Trial. J Am Coll Cardiol. 2026. PMID: 42670732. doi:10.1016/j.jacc.2026.08.036

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。